Short talks Pharmacology 4
Immunopharmacology and inflammation

Programme

• 09:00 – 09:15 10 Min. 5 Min.

  • Oral presentation
  • 15

  Individuals with weaker humoral response after second booster vaccination are prone to SARS-CoV-2 Omicron BA.5 infections

  • Birte Möhlendick (Essen / DE)

   Disease models, drug development, Immunopharmacology / inflammation / anti-infectives
• 09:15 – 09:30 10 Min. 5 Min.

  • Oral presentation
  • 16

  LPS-neutralizing peptides modulate NLRP3-mediated IL-1β secretion

  • Jonas Engelhardt (Bonn / DE)

   Immunopharmacology / inflammation / anti-infectives , Toxins
• 09:30 – 09:45 10 Min. 5 Min.

  • Oral presentation
  • 17

  PD-L1 upregulation by proximal complement activation – a mechanistic model with various clinical implications

  • Susanne Hafner (Ulm / DE)

   Disease models, drug development, Immunopharmacology / inflammation / anti-infectives
• 09:45 – 10:00 10 Min. 5 Min.

  • Oral presentation
  • 18

  3D lung-organoid reporter platform for testing of pharmaceutical compounds via high-throughput screening

  • Daniela Yildiz née Dreymueller (Homburg / DE)

   Disease models, drug development, Immunopharmacology / inflammation / anti-infectives
• 10:00 – 10:15 10 Min. 5 Min.

  • Oral presentation
  • 19

  Myeloid-derived suppressor cells dampen airway inflammation through prostaglandin E2 receptor 4

  • Saeed Kolahian (Marburg / DE)

   Disease models, drug development, Immunopharmacology / inflammation / anti-infectives
• 10:15 – 10:30 10 Min. 5 Min.

  • Online Lecture
  • 20

  Bupropion Ameliorates Acetic Acid-Induced Colitis in Rat: The Involvement of the TLR4/NF-kB Signaling Pathway

  • Kiana Karamifard (KhorramAbad / IR)

   Immunopharmacology / inflammation / anti-infectives